Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Multiple Sclerosis
17. June 2025
Search
medline.ch
Multiple Sclerosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2080
Articles 1 - 20 / 41600
Determining the Effects of Emotional Freedom Techniques on Sexual Dysfunction and Self-Care Management in Women Diagnosed With Multiple Sclerosis.
Brain Behav
Çuvadar A, Güne, Ba, Kehaya S.
PMID: 40525294 [PubMed - indexed for MEDLINE]
Prevalence of multiple sclerosis in Spain. Estimates from the Primary Care Clinical Database (BDCAP).
Neurologia (Engl Ed)
Cayuela L, García-Muñoz C, Sainz de la Maza S, Cayuela A.
PMID: 40523714 [PubMed - indexed for MEDLINE]
Unraveling the Role of THRIL/miR-137 in Fine-Tuning the Immunological Transcriptional Loop STAT4/STAT6/GATA3 in Multiple Sclerosis: Implications on Neurological Complications and Disease Subtypes.
ACS Chem Neurosci
Ayeldeen G, Badr BM, Awaji AA, Gaber DA, Elelwany DA, Al Abdulqader AK, Shaker OG, Abd-Elmawla MA.
PMID: 40523308 [PubMed - as supplied by publisher]
Diagnostic Accuracy of Isotropic FLAIR-T2* Fusion Imaging for Central Vein Sign Detection in Multiple Sclerosis: a Comparative Study at 1.5 T and 3 T.
Clin Neuroradiol
Senturk YE, Peker A, Ozen Atalay H, Altintas A, Oner AY.
PMID: 40522462 [PubMed - as supplied by publisher]
Blood-brain barrier permeability in relation to disease severity and timing of multiple sclerosis diagnosis in optic neuritis.
Mult Scler J Exp Transl Clin
Passali M, Knudsen MH, Josefsen K, Antvorskov JC, Hindsholm AM, Lindberg U, Frederiksen JL, Larsson HBW, Cramer SP.
PMID: 40520967 [PubMed]
Voice Quality in Multiple Sclerosis: A Clinical Perspective on Cepstral Peak Prominence-Smoothed and Harmonic-to-Noise Ratio.
J Voice
Fusari G, Torchio A, Baldanzi C, Isernia S, Crispiatico V, Rovaris M, Sgrò D, Vitali C, Carullo A, Cattaneo D.
PMID: 40518355 [PubMed - as supplied by publisher]
Multiple sclerosis from onset to secondary progression: a 30-year Italian register study.
J Neurol Neurosurg Psychiatry
Zanghì A, Copetti M, Avolio C, Paolicelli D, Romeo MAL, Patti F, De Luca G, Amato MP, Galgani S, Sola P, Salemi G, Gallo P, Granella F, Romano S, Zaffaroni M, Bergamaschi R, Pozzilli C, Lus G, Vianello M, Trojano M, D'Amico E, Italian Multiple Sclerosis register.
PMID: 40518265 [PubMed - as supplied by publisher]
Power Training in Older People with Multiple Sclerosis - the PoTOMS trial (PhD Academy Award).
Br J Sports Med
Gaemelke T.
PMID: 40518174 [PubMed - as supplied by publisher]
Segmentation with artificial intelligence and automated calculation of the corpus callosum index in multiple sclerosis.
Saudi Med J
Demirbas S, Karaali K, Albayrak Y, Fidan N.
PMID: 40516948 [PubMed - indexed for MEDLINE]
A comparison of JC virus assay performance provided with originator and biosimilar natalizumab.
Mult Scler
Varley J, Beyrouti R, Nicholas R, Dorsey R, Brownlee W, Paling D, Mathews J, Dobson R.
PMID: 40515643 [PubMed - indexed for MEDLINE]
Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?
Mult Scler
Vukusic S, Hubben F, Gavoille A, Malek Y, Casez O, Kremer L, Palpacuer T, Marignier R, Durand-Dubief F, Androdias-Condemine G, Pique J, Maillart E, Vermersch P, de Seze J.
PMID: 40515642 [PubMed - indexed for MEDLINE]
Speech as a digital biomarker in multiple sclerosis: Automatic analysis of speech metrics using a multi-speech-task protocol in a cross-sectional MS cohort study.
Mult Scler
Garthof S, Schäfer S, Elmers J, Schwed L, Linz N, Boggiano T, Chatham C, Overell J, Hayward-Koennecke H, Tröger J, Dillenseger A, Tackenberg B, Ziemssen T.
PMID: 40515641 [PubMed - indexed for MEDLINE]
Pharmacokinetic-pharmacodynamic modelling in a clinical pilot study of rituximab in multiple sclerosis: Towards personalized dosing interval.
Br J Clin Pharmacol
Serkland TT, Skrede S, Hallin EI, Myhr KM, Torkildsen Ø, Röblitz S.
PMID: 40515509 [PubMed - as supplied by publisher]
Multiple sclerosis is associated with worse body composition across compartments: Results from a systematic review and meta-analysis.
Mult Scler Relat Disord
Pilutti LA, Silveira SL, Herring MP, Jeng B, Edwards T, Cederberg KLJ, Fournier K, Motl RW.
PMID: 40513309 [PubMed - as supplied by publisher]
Protective effect of the Quercetin on experimental cuprizone-induced multiple sclerosis in male C57BL/6 mice.
Curr Res Physiol
Ghasemi S, Hassanpour S, Hosseini R.
PMID: 40511293 [PubMed]
Erratum: Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies: A Real-World Pharmacovigilance Study.
Neurol Clin Pract
Balshi A, Leuenberger G, Dempsey J, Manning N, Baber U, Sloane JA.
PMID: 40510873 [PubMed]
Progression independent of relapsing biology in multiple sclerosis: a real-word study.
Front Neurol
Yong HYF, Camara-Lemarroy C.
PMID: 40510203 [PubMed]
Effectiveness of disease-modifying agents in ameliorating multiple sclerosis - A cross-sectional observational study.
Indian J Pharmacol
Jayachandran M, Sacheendran D, Kuriachan S, Palatty PL, Ravindran GC.
PMID: 40509763 [PubMed - indexed for MEDLINE]
Reducing Stigma, Enhancing Psychological Well-Being and Identity in Multiple Sclerosis: A Narrative Review of Current Practices and Future Directions.
Healthcare (Basel)
Montesano C, Liberali G, Azzali G, Buzzachera C, Angilletta S, Alessandria M, Guidetti L, De Giorgio A.
PMID: 40508904 [PubMed]
The Role of Inflammation in Neurodegenerative Diseases: Parkinson's Disease, Alzheimer's Disease, and Multiple Sclerosis.
Int J Mol Sci
Fo, Rzepka Z, Wrze.
PMID: 40507988 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 41600
Page 1 of 2080
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy